35 reports

  • Target

Heart Transplant Rejection Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Heart Transplant Rejection Global Clinical Trials Review, H2, 2017" provides an overview of Heart Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical...

  • Heart Transplant
  • Pharmaceutical
  • Targeted Therapy
  • World
  • Novartis AG

Each Unit consists of one Common Share and one Warrant of the Corporation.

  • Lung Cancer
  • Targeted Therapy
  • United States
  • World
  • Product Initiative
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Monoclonal Antibody
  • Targeted Therapy
  • World

The prominent features of this report are - ##.

  • Clinical Trial
  • Monoclonal Antibody
  • Targeted Therapy
  • World
  • Teva Pharmaceutical Industries Ltd.

Each Unit consists of one Common Share and one Warrant of the Corporation.

  • Lung Cancer
  • Targeted Therapy
  • Therapy
  • United States
  • Product Initiative

The prominent features of this report are - ##.

  • Cancer
  • Targeted Therapy
  • Therapy
  • World
  • Product Initiative

Endo International Plc Ark Therapeutics Ltd Aeterna Zentaris Inc Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2017 2017 trials are taken as of May 2017 ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Cancer
  • Targeted Therapy
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 1618 Trial Title

Patients with HER##-high breast cancer (HER## IHC ##+ or IHC##+ and FISH-positive) had to have received previous treatment with trastuzumab, pertuzumab, and T-DM##.

  • Breast Cancer
  • Drug Discovery And Development
  • Targeted Therapy
  • World
  • F. Hoffmann-La Roche Ltd.

The prominent features of this report are - ##.

  • Cancer
  • Clinic
  • Sexually Transmitted Disease
  • Targeted Therapy
  • Merck & Co., Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Cardiology
  • Clinical Trial
  • Targeted Therapy
  • Therapy
  • World

The prominent features of this report are - ##.

  • Clinical Trial
  • Cytokine
  • Neurological Disorder
  • Targeted Therapy
  • Biogen Idec Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## Sarah Cannon Research Institute LLC ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## ## ## AstraZeneca Plc ## ## ## ## ## ##

  • Clinical Trial
  • Drug Discovery And Development
  • Targeted Therapy
  • World
  • Product Initiative

Its diet supplements comprise fish oil soft capsule, glucosamine sulphate ##kcl capsule, spirulina tablet, evening primrose oil soft capsule, natural vitamin e soft capsule, evening primrose oil soft capsule, and others.

  • Digestive System Disorder
  • Targeted Therapy
  • Therapy
  • United States
  • Product Initiative

## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## Canada Source: GlobalData' s Phar

  • General Medicine And Specialty Medicine
  • Targeted Therapy
  • Therapy
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Drug Discovery And Development
  • Pharmaceutical
  • Targeted Therapy
  • United States
  • World

One MDS patient experienced a PR.

  • Leukemia
  • Monoclonal Antibody
  • Pharmaceutical
  • Targeted Therapy
  • World

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Drug Discovery And Development
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Targeted Therapy
  • World
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## AstraZeneca Plc ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Bristol-Myers Squibb Co ## ## ## ## ## ## ## ## UCB SA ## ## ## ## ## ## ## ## Celgene Corp ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Q

  • Clinical Trial
  • Cytokine
  • Targeted Therapy
  • World
  • GlaxoSmithKline plc

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## ## Bristol-Myers Squibb Co ## ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## ## Chiesi Farmaceutici SpA ## ## ## ## ## ## ## ## ## Alexion Pharmaceuticals Inc ## ## ## ##

  • Clinical Trial
  • Drug Discovery And Development
  • Targeted Therapy
  • World
  • Novartis AG
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Targeted Therapy
  • Therapy
  • World

## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## ## Source

  • Blood Disease
  • General Medicine And Specialty Medicine
  • Targeted Therapy
  • World
  • Product Initiative
  • Indication Name

Its diet supplements comprise fish oil soft capsule, glucosamine sulphate ##kcl capsule, spirulina tablet, evening primrose oil soft capsule, natural vitamin e soft capsule, evening primrose oil soft capsule, and others.

  • Breast Cancer
  • Pharmaceutical
  • Targeted Therapy
  • United States
  • Product Initiative

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Targeted Therapy
  • World
  • Product Initiative

ITS DIET SUPPLEMENTS COMPRISE FISH OIL SOFT CAPSULE, GLUCOSAMINE SULPHATE ##KCL CAPSULE, SPIRULINA TABLET, EVENING PRIMROSE OIL SOFT CAPSULE, NATURAL VITAMIN E SOFT CAPSULE, EVENING PRIMROSE OIL SOFT CAPSULE, AND OTHERS.

  • Cancer
  • Pharmaceutical
  • Targeted Therapy
  • United States
  • Product Initiative

The preferential mobilization of AML blasts over normal cells (##. ##-fold vs. ##. ##-fold, respectively) was further confirmed by FISH analysis in a subset of patients.

  • Leukemia
  • Targeted Therapy
  • Therapy
  • United States
  • Bristol-Myers Squibb Company

The preferential mobilization of AML blasts over normal cells (##. ##-fold vs. ##. ##-fold, respectively) was further confirmed by FISH analysis in a subset of patients.

  • Cancer
  • Targeted Therapy
  • United States
  • Product Initiative
  • Bristol-Myers Squibb Company
  • Clinical Trial profile. 87 Trial Title

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Pharmaceutical
  • Targeted Therapy
  • World

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Pharmaceutical
  • Targeted Therapy
  • World

Its diet supplements comprise fish oil JIANGSU KANION PHARMACEUTICAL CO LTD ALZHEIMER' S DISEASE - PIPELINE BY JEIL PHARMACEUTICAL CO LTD, H## 2018 soft capsule, glucosamine sulphate ##kcl capsule, spirulina tablet, evening primrose oil soft capsule, natural vitamin e so

  • Dementia
  • Pathology
  • Research And Development
  • Targeted Therapy
  • Anavex Life Sciences Corp.

Each Unit consists of one Common Share and one Warrant of the Corporation.

  • Monoclonal Antibody
  • Targeted Therapy
  • United States
  • Product Initiative
  • Cellceutix Corporation